We're backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.
New treatments for pancreatic cancer are set to be transformed by a network of clinical trials - to find the right trial for the right patient.
New research by our scientists may have found a way to target a faulty cell suicide pathway in cancer.
Combining new ways to measure molecules could lead to the most accurate picture of tumours ever created. We explore the science behind the approach.
Cancer Research Technology and Varleigh DX (UK) Ltd launch test to support diagnosis of pancreatic cancer
Cancer Research Technology and Varleigh Dx have jointly launched a new test as an aid in the diagnosis of patients with pancreatic cancer.
Diabetes and pancreatic cancer are linked, but how?
Scientists have revealed an interaction between pancreatic cancer cells and their environment, which could lead to a new way of predicting patient outlook.
An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.